Sverluse Macova

Title: The Innovations of Sverluse Macova

Introduction

Sverluse Macova is a notable inventor based in Prague, Czech Republic. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with antihypertensive properties. His work has implications for medical treatments and showcases the importance of innovation in healthcare.

Latest Patents

Sverluse Macova holds a patent for "Substituted acylpiperazinoquinazolines and pharmaceutical compositions." This patent describes substituted acylpiperazinoquinazolines of formula I, where n is 0 or 1, R represents an alkyl group with 1 to 4 carbon atoms or a benzyl group, and R1 is a hydrogen atom, a methyl group, or a phenyl group. The patent also discloses addition salts of these compounds with inorganic and organic acids. The compounds exhibit significant antihypertensive activity and can be synthesized through the reaction of 2-halogeno quinazoline derivatives with the corresponding acylpiperazines. The resulting acid addition salts, particularly hydrochlorides, are soluble in water and suitable for parenteral and peroral medicinal dosage forms.

Career Highlights

Sverluse Macova is associated with Spofa, Spojene Podniky Pro Zdravotnickou Vyrobu, a company dedicated to healthcare products. His work at Spofa has allowed him to focus on innovative pharmaceutical solutions that address critical health issues.

Collaborations

Sverluse has collaborated with notable colleagues such as Jan Koenig and Miroslav Rajsner. Their combined expertise has contributed to advancements in the pharmaceutical field.

Conclusion

Sverluse Macova's contributions to pharmaceutical innovations highlight the vital role of inventors in advancing healthcare solutions. His patent on antihypertensive compounds demonstrates the potential for scientific research to lead to effective medical treatments.